This Article Full Text Full Text (PDF) All Versions of this Article: 0008-5472.CAN-08-2708v1 69/3/753    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sankpal, N. V. Articles by Gillanders, W. E. Search for Related Content PubMed PubMed Citation Articles by Sankpal, N. V. Articles by Gillanders, W. E.

Transcriptional Repression of Epithelial Cell Adhesion Molecule Contributes to p53 Control of Breast Cancer Invasion

Section of Endocrine and Oncologic Surgery, Washington University School of Medicine, St. Louis, Missouri

Requests for reprints: William E. Gillanders, Section of Endocrine and Oncologic Surgery, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO 63110. Phone: 314-747-0072; Fax: 314-454-5509; E-mail: gillandersw{at}wustl.edu.

Key Words: p53 • EpCAM • breast cancer • invasion

p53 is a tumor suppressor gene with well-characterized roles in cell cycle regulation, apoptosis, and maintenance of genome stability. Recent evidence suggests that p53 may also contribute to the regulation of migration and invasion. Epithelial cell adhesion molecule (EpCAM) is a transmembrane glycoprotein that is overexpressed in the majority of human epithelial carcinomas, including breast and colorectal carcinomas. We show by chromatin immunoprecipitation assays that p53 interacts with a candidate p53 binding site within the EpCAM gene. p53-mediated transcriptional repression of EpCAM was confirmed in gain-of-function and loss-of-function experimental systems. Induction of wild-type p53 was associated with a significant dose-dependent decrease in EpCAM expression; conversely, specific ablation of p53 was associated with a significant increase in EpCAM expression. At the functional level, specific ablation of p53 expression is associated with increased breast cancer invasion, and this effect is abrogated by concomitant specific ablation of EpCAM expression. Taken together, these biochemical and functional data are the first demonstration that (a) wild-type p53 protein binds to a response element within the EpCAM gene and negatively regulates EpCAM expression, and (b) transcriptional repression of EpCAM contributes to p53 control of breast cancer invasion. [Cancer Res 2009;69(3):753–7]

This article has been cited by other articles:

				M. Munz, P. A. Baeuerle, and O. Gires The Emerging Role of EpCAM in Cancer and Stem Cell Signaling Cancer Res., July 15, 2009; 69(14): 5627 - 5629. [Abstract] [Full Text] [PDF]